Flebogamma DIF (previously Flebogammadif) Den Europæiske Union - fransk - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - l'immunoglobuline humaine normale - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - des sérums et immunoglobulines, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

VISTASEAL Solution Canada - fransk - Health Canada

vistaseal solution

instituto grifols s.a. - fibrinogène (humaine); thrombine (humaine) - solution - 80mg; 500unité - fibrinogène (humaine) 80mg; thrombine (humaine) 500unité - hemostatics

VISTASEAL Solution Canada - fransk - Health Canada

vistaseal solution

instituto grifols s.a. - fibrinogène (humaine); thrombine (humaine) - solution - 160mg; 1000unité - fibrinogène (humaine) 160mg; thrombine (humaine) 1000unité - hemostatics

VISTASEAL Solution Canada - fransk - Health Canada

vistaseal solution

instituto grifols s.a. - thrombine (humaine); fibrinogène (humaine) - solution - 1500unité; 240mg - thrombine (humaine) 1500unité; fibrinogène (humaine) 240mg - hemostatics

VISTASEAL Solution Canada - fransk - Health Canada

vistaseal solution

instituto grifols s.a. - fibrinogène (humaine); thrombine (humaine) - solution - 400mg; 2500unité - fibrinogène (humaine) 400mg; thrombine (humaine) 2500unité - hemostatics

VeraSeal Den Europæiske Union - fransk - EMA (European Medicines Agency)

veraseal

instituto grifols, s.a. - fibrinogène humain, thrombine humaine - hémostase chirurgicale - antihémorragiques - un traitement de soutien dans les adultes, où les techniques chirurgicales standard sont insuffisants:pour l'amélioration de la haemostasisas support de suture en chirurgie vasculaire.

Tavlesse Den Europæiske Union - fransk - EMA (European Medicines Agency)

tavlesse

instituto grifols s.a. - fostamatinib disodique - thrombocytopénie - d'autres systémique hémostatiques - tavlesse est indiqué pour le traitement de la thrombopénie immune (pti) chez les patients adultes qui sont réfractaires aux autres traitements.

Choriomon 10'000 polvere e solvente per soluzione iniettabile (fiala con solvente) Schweiz - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

choriomon 10'000 polvere e solvente per soluzione iniettabile (fiala con solvente)

ibsa institut biochimique sa - gonadotrophinum chorionicum - polvere e solvente per soluzione iniettabile (fiala con solvente) - praeparatio cryodesiccata: gonadotrophinum chorionicum 10000 u.i. hcg, lactosum monohydricum, pro vitro. solvens: natrii chloridum corresp. natrium 3.54 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - l'aménorrhée, l'anovulation; la cryptorchidie, l'hypogonadisme ipogonadotropinico, pubertas tarda.; la stimulation des follicules dans la reproduction médicalement assistée. - biotechnologika

Choriomon 1500 polvere e solvente per soluzione iniettabile (fiala con solvente) Schweiz - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

choriomon 1500 polvere e solvente per soluzione iniettabile (fiala con solvente)

ibsa institut biochimique sa - gonadotrophinum chorionicum - polvere e solvente per soluzione iniettabile (fiala con solvente) - praeparatio cryodesiccata: gonadotrophinum chorionicum 1500 u.i. hcg, lactosum monohydricum, pro vitro. solvens: natrii chloridum corresp. natrium 3.54 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - l'aménorrhée, l'anovulation; la cryptorchidie, l'hypogonadisme ipogonadotropinico, pubertas tarda.; la stimulation des follicules dans la reproduction médicalement assistée. - biotechnologika